重组管瓶适配器市场规模、份额、成长分析（按应用、按材料类型、按产品类型、按最终用途、按地区）- 行业预测 2025-2032

2023 年全球重构药物管瓶转接器市场规模为 22 亿美元，预计将从 2024 年的 24 亿美元成长到 2032 年的 47.8 亿美元，预测期内（2025-2032 年）的复合年增长率为 9.0%。

癌症和糖尿病等慢性疾病的日益普及以及感染疾病的持续威胁，推动了对需要復溶的注射疗法的需求。在这种情况下，管瓶适配器变得至关重要，因为它们有助于将稀释剂安全有效地转移到管瓶中，从而简化復溶过程。随着对复杂疗法的需求不断增加，这些设备有助于减少用药错误，提高病人安全性，并在各种情况下改善疗效。遵守严格的药物处理和给药安全监管标准至关重要，而药瓶适配器符合这些要求，可最大限度地减少污染并保护医护人员免受危险暴露。随着重视病患安全和业务效率的医院和诊所越来越多地采用管瓶适配器，管瓶适配器已成为现代医疗保健的重要工具。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析

重组管瓶适配器市场规模（按应用）及复合年增长率（2025-2032）

• 市场概览
• 肿瘤学
• 自体免疫疾病
• 感染疾病
• 遗传性疾病
• 荷尔蒙补充疗法

重组管瓶适配器市场规模（按材料类型和复合年增长率） (2025-2032)

• 市场概览
• 塑胶
• 玻璃
• 橡皮
• 硅胶
• 金属

重组管瓶适配器市场规模（按产品类型和复合年增长率） (2025-2032)

• 市场概览
• 一次性管瓶适配器
• 多用途管瓶转接器
• 客製化管瓶转接器

重组管瓶适配器市场规模（按最终用途和复合年增长率） (2025-2032)

• 市场概览
• 製药公司
• 契约製造组织
• 研究组织
• 医院
• 零售药局

重构管瓶转接器市场规模（按地区及复合年增长率）（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• West Pharmaceutical Services, Inc.（USA）
• Becton, Dickinson and Company（BD）（USA）
• Gerresheimer AG（Germany）
• SCHOTT AG（Germany）
• Parker Hannifin Corporation（USA）
• AptarGroup, Inc.（USA）
• SteriPack Group（Ireland）
• Roxar（Italy）
• Nemera（France）
• Biocorp（France）
• Ypsomed AG（Switzerland）
• Vetter Pharma-Fertigung GmbH & Co. KG（Germany）
• Ompi（Stevanato Group）（Italy）
• Hapco（USA）
• Baxter International Inc.（USA）
• B. Braun SE（Germany）
• Miltenyi Biotec GmbH（Germany）
• Cardinal Health, Inc.（USA）
• Simplivia Healthcare Ltd.（Israel）
• EQUASHIELD LLC（USA）

结论和建议

Global Vial Adaptors for Reconstitution Drug Market size was valued at USD 2.2 billion in 2023 and is poised to grow from USD 2.4 billion in 2024 to USD 4.78 billion by 2032, growing at a CAGR of 9.0% during the forecast period (2025-2032).

The increasing incidence of chronic diseases, such as cancer and diabetes, along with ongoing infectious disease challenges, is propelling the demand for injectable therapies requiring reconstitution. Vial adaptors are becoming essential in this context, facilitating a safe and efficient transfer of diluents into drug vials, thus streamlining the reconstitution process. As complex therapy demands rise, these devices help mitigate medication errors, enhance patient safety, and improve outcomes in various settings. Compliance with stringent regulatory standards regarding drug handling and administration safety is crucial, and vial adaptors meet these requirements, minimizing contamination and protecting healthcare workers from hazardous exposure. Their adoption is growing in hospitals and clinics, driven by the focus on patient safety and operational efficiency, marking them as vital tools in modern healthcare.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Vial Adaptors for Reconstitution Drug market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Vial Adaptors for Reconstitution Drug Market Segments Analysis

Global Vial Adaptors for Reconstitution Drug Market is segmented by Application, Material Type, Product Type, End Use and region. Based on Application, the market is segmented into Oncology, Autoimmune Diseases, Infectious Diseases, Genetic Disorders and Hormonal Replacement. Based on Material Type, the market is segmented into Plastic, Glass, Rubber, Silicone and Metal. Based on Product Type, the market is segmented into Single-Use Vial Adaptors, Multi-Use Vial Adaptors and Customized Vial Adaptors. Based on End Use, the market is segmented into Pharmaceutical Companies, Contract Manufacturing Organizations, Research Institutions, Hospitals and Retail Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Vial Adaptors for Reconstitution Drug Market

The global market for vial adaptors designed for reconstituting drugs is witnessing significant growth propelled by the rising demand for biologic medications, such as monoclonal antibodies and gene therapies. These advanced therapeutics typically necessitate reconstitution before they can be administered, leading to a heightened requirement for dependable and effective vial adaptors. These devices play a crucial role in facilitating the accurate and safe delivery of complex biologics, ensuring that patients receive the intended dosage without any compromises in quality or efficacy. This trend underscores the importance of innovative solutions in the pharmaceutical industry to enhance drug administration processes.

Restraints in the Global Vial Adaptors for Reconstitution Drug Market

The global vial adaptors market for drug reconstitution faces significant restraints due to the absence of uniform standards across the industry. Differences in design, materials, and functionalities among various regions and pharmaceutical companies create compatibility challenges, which can undermine the effectiveness and safety of the drug reconstitution process. These inconsistencies not only pose risks to patient care but also hinder the market's growth potential. As a result, the lack of standardization remains a critical barrier that needs to be addressed to enhance market efficiency and ensure the safe and effective use of vial adaptors in drug reconstitution.

Market Trends of the Global Vial Adaptors for Reconstitution Drug Market

The global vial adaptors for reconstitution drug market is experiencing significant growth, propelled by the rising adoption of biologics and biosimilars in therapeutic applications. As the pharmaceutical industry expands its focus on complex biologic formulations, the need for accurate and safe reconstitution methods becomes paramount. Vial adaptors play a critical role in facilitating seamless drug delivery, ensuring optimal efficacy and patient safety. Furthermore, the increasing emphasis on precision medicine and tailored therapies is further intensifying the demand for these devices. As more healthcare providers and biopharmaceutical companies recognize the value of vial adaptors, the market is poised for robust expansion in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Vial Adaptors for Reconstitution Drug Market Size by Application & CAGR (2025-2032)

• Market Overview
• Oncology
• Autoimmune Diseases
• Infectious Diseases
• Genetic Disorders
• Hormonal Replacement

Global Vial Adaptors for Reconstitution Drug Market Size by Material Type & CAGR (2025-2032)

• Market Overview
• Plastic
• Glass
• Rubber
• Silicone
• Metal

Global Vial Adaptors for Reconstitution Drug Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Single-Use Vial Adaptors
• Multi-Use Vial Adaptors
• Customized Vial Adaptors

Global Vial Adaptors for Reconstitution Drug Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Pharmaceutical Companies
• Contract Manufacturing Organizations
• Research Institutions
• Hospitals
• Retail Pharmacies

Global Vial Adaptors for Reconstitution Drug Market Size & CAGR (2025-2032)

• North America (Application, Material Type, Product Type, End Use)
  • US
  • Canada
• Europe (Application, Material Type, Product Type, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Application, Material Type, Product Type, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Application, Material Type, Product Type, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Application, Material Type, Product Type, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• West Pharmaceutical Services, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gerresheimer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SCHOTT AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parker Hannifin Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AptarGroup, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SteriPack Group (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roxar (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nemera (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocorp (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetter Pharma-Fertigung GmbH & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ompi (Stevanato Group) (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hapco (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Simplivia Healthcare Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EQUASHIELD LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations